Literature DB >> 17293662

A case of renal cancer with TFE3 gene fusion in an elderly man. Clinical, radiological and surgical findings.

Aldo Franzini1, Stefano Carlo Maria Picozzi, Paolo Luca Politi, Luigi Barana, Fabio Bianchi, Giuseppe Alfano, Giampiera Gatti, Franco Fanciullacci, Massimo Gariboldi, Mirella Strada, Biagio Eugenio Leone.   

Abstract

Sporadic cases of a particular group of renal cancers associated with a translocation involving Xp11.2, known as the TFE3 transcription factor gene, have been reported in the last 20 years. The group was also classified in 2004 WHO kidney carcinoma classifications. A 79-year-old male patient was investigated at the outpatient department for gross intermittent hematuria. Sonography showed a spherical left kidney with increased total size, without evidence of the corticomedullary differentiation due to parenchymal dyshomogeneity with a neoplasm aspect. CT confirmed the sonographic left kidney findings and showed gross node involvement. Angiography did not show any pathological arterial circulation, but massive thrombotic involvement of the renal vein was evident. Radical nephrectomy with thrombectomy and staging lymphectomy were performed. At pathological examination the kidney parenchyma was completely substituted by white firm tissue. Microscopically the tumor was composed of papillary structures lined by epithelial cells with a clear cytoplasm. Multiple node metastases were found. Immunohistochemical examination showed negativity for epithelial markers (cytokeratin and epithelial membrane antigen) and reactivity for CD10 and TFE3. The genetic and histological aspects of this rare tumor are reported. In addition, we describe clinical, radiological and surgical findings. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293662     DOI: 10.1159/000098080

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.

Authors:  Toshihiko Masago; Susumu Kobayakawa; Yuu Ohtani; Kenjirou Taniguchi; Takuji Naka; Naoto Kuroda; Chihiro Takahashi; Tadahiro Isoyama; Takehiro Sejima
Journal:  Int Cancer Conf J       Date:  2020-07-08

2.  A distinctive translocation carcinoma of the kidney ["rosette-like forming," t(6;11), HMB45-positive renal tumor].

Authors:  Milan Hora; Ondrej Hes; Tomás Urge; Viktor Eret; Jirí Klecka; Michal Michal
Journal:  Int Urol Nephrol       Date:  2008-11-08       Impact factor: 2.370

3.  Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.

Authors:  Brian N Chorley; Michelle R Campbell; Xuting Wang; Mehmet Karaca; Deepa Sambandan; Fatu Bangura; Peng Xue; Jingbo Pi; Steven R Kleeberger; Douglas A Bell
Journal:  Nucleic Acids Res       Date:  2012-05-11       Impact factor: 16.971

4.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13

5.  Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma.

Authors:  Arash Akhavein; Julia Han; Christopher Carter; Samer Z Al-Quran; Li-Ming Su
Journal:  Urol Case Rep       Date:  2014-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.